Revance Therapeutics, Inc.

NasdaqGM:RVNC Stock Report

Market Cap: US$381.4m

Revance Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:RVNC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Apr 24SellUS$9,096Erica JordanIndividual2,392US$3.80
18 Mar 24SellUS$40,971Dwight MoxieIndividual8,125US$5.04
18 Mar 24SellUS$46,446Dustin SjutsIndividual9,211US$5.04
18 Mar 24SellUS$47,204Tobin SchilkeIndividual9,361US$5.04
06 Mar 24BuyUS$209,400Mark FoleyIndividual30,000US$6.98
20 Oct 23BuyUS$18,847,963Teoxane S.A.Company2,105,000US$9.44
22 Aug 23BuyUS$28,129,440Teoxane S.A.Company1,392,000US$25.88
15 May 23SellUS$726,003Dustin SjutsIndividual21,015US$34.55
15 May 23SellUS$2,433,725Mark FoleyIndividual70,447US$34.55
15 May 23SellUS$739,338Tobin SchilkeIndividual21,401US$34.55
15 May 23SellUS$739,338Dwight MoxieIndividual21,401US$34.55

Insider Trading Volume

Insider Buying: RVNC insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of RVNC?
Owner TypeNumber of SharesOwnership Percentage
State or Government1,359,0921.3%
Individual Insiders1,700,9541.63%
Hedge Funds5,237,2845.03%
Sovereign Wealth Funds5,825,8815.59%
Private Companies6,557,6236.29%
General Public17,799,64517.1%
Institutions65,735,13563.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.3%.


Top Shareholders

Top 25 shareholders own 68.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.5%
Capital Research and Management Company
11,939,076US$43.7m-0.18%no data
7.15%
BlackRock, Inc.
7,453,371US$27.3m10.3%no data
6.29%
Teoxane S.A.
6,550,800US$24.0m47.4%no data
5.59%
GIC Private Limited
5,825,881US$21.3m40.9%0.03%
5.03%
Palo Alto Investors LP
5,237,284US$19.2m0.17%2.18%
4.86%
The Vanguard Group, Inc.
5,069,625US$18.6m5.81%no data
4.52%
Franklin Resources, Inc.
4,705,640US$17.2m17.7%0.01%
3.04%
Polar Capital Holdings Plc
3,169,239US$11.6m-23.8%0.05%
2.56%
JP Morgan Asset Management
2,666,144US$9.8m-40.1%no data
2.42%
State Street Global Advisors, Inc.
2,521,693US$9.2m8.08%no data
1.85%
Geode Capital Management, LLC
1,924,421US$7.0m8.1%no data
1.53%
Invesco Ltd.
1,595,091US$5.8m-44.9%no data
1.4%
Rubric Capital Management LP
1,461,474US$5.3m-8.66%0.18%
1.3%
Monetary Authority of Singapore
1,359,092US$5.0m0%no data
1.1%
CIBC Asset Management Inc.
1,147,294US$4.2m251%0.01%
1.06%
Mark Foley
1,105,848US$4.0m7.82%no data
0.99%
Jennison Associates LLC
1,032,352US$3.8m3.48%no data
0.98%
Baron Capital Group, Inc.
1,023,663US$3.7m0.34%0.01%
0.93%
Walleye Capital LLC
970,586US$3.6m205%0.03%
0.85%
Northern Trust Global Investments
887,536US$3.2m5.87%no data
0.73%
Rice Hall James & Associates, LLC
758,048US$2.8m10.8%0.18%
0.68%
Morgan Stanley, Investment Banking and Brokerage Investments
708,314US$2.6m95.9%no data
0.66%
Goldman Sachs Group, Investment Banking and Securities Investments
687,534US$2.5m-33.9%no data
0.65%
Charles Schwab Investment Management, Inc.
677,364US$2.5m0%no data
0.6%
EULAV Asset Management
630,000US$2.3m5%0.07%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.